Itraconazole therapy for cryptococcal meningitis and cryptococcosis
- 1 October 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 149 (10), 2301-2308
- https://doi.org/10.1001/archinte.149.10.2301
Abstract
Research from JAMA Internal Medicine — Itraconazole Therapy for Cryptococcal Meningitis and CryptococcosisThis publication has 16 references indexed in Scilit:
- Effect of buffers on testing of Candida species susceptibility to flucytosineJournal of Clinical Microbiology, 1987
- Itraconazole for Cryptococcal Infection in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1987
- Cryptococcal infections in patients with acquired immune deficiency syndromeThe American Journal of Medicine, 1986
- Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbitsAntimicrobial Agents and Chemotherapy, 1986
- Cryptococcal Disease in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Cryptococcosis in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- In vitro studies with R 51,211 (itraconazole)Antimicrobial Agents and Chemotherapy, 1984
- R 51211 (itraconazole) therapy of murine cryptococcosisMedical Mycology, 1984
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979
- Prognostic Factors in Cryptococcal MeningitisAnnals of Internal Medicine, 1974